Armen Shanafelt

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ Jessica Fees, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Armen Shanafelt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. Director Common Stock 150,000 $84,120 $0.5608 13 Dec 2021 Direct
Aeglea BioTherapeutics, Inc. Director Director Stock Option (right to buy) 43,000 07 Jun 2022 Direct
Surface Oncology, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 24,000 08 Jun 2022 Direct

Insider Reports Filed by Armen Shanafelt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122036150-shanafelt-armen-2022-06-08 Surface Oncology, Inc. 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 20:00
SYRE Aeglea BioTherapeutics, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 21:22
SYRE Aeglea BioTherapeutics, Inc. 09 Dec 2021 3 +$549,692 4 Director 13 Dec 2021, 19:41
/report/000120919121039460-shanafelt-armen-2021-06-08 Surface Oncology, Inc. 08 Jun 2021 1 $0 4 Director, 10%+ Owner 10 Jun 2021, 16:30
SYRE Aeglea BioTherapeutics, Inc. 08 Jun 2021 1 $0 4 Director 09 Jun 2021, 17:27